Fat and flu: fact or fiction?

Novel risk factors for severe influenza infection were described during the early phases of the influenza pandemic of 2009. Worldwide, the rate of severe influenza in the obese and morbidly obese population was disproportionate to that of the general population. This risk factor has now been recognized presumably due to the increasing prevalence of obesity. The cause behind this trend may extend beyond the known deleterious effects of obesity on respiratory physiology, as emerging evidence in animal models demonstrate A(H1N1)pdm09 itself confers worse outcomes compared with seasonal influenza subtypes. Currently, uncertainty remains regarding the optimal antiviral regimen and vaccination strategies in obese individuals. Therefore, further studies on the effects of obesity on influenza infection need to be prioritized.

[1]  G. Aldrovandi,et al.  Influenza Vaccine is Protective Against Laboratory-confirmed Influenza in Obese Children , 2016, The Pediatric infectious disease journal.

[2]  N. Day,et al.  Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers , 2016, British journal of clinical pharmacology.

[3]  E. Montomoli,et al.  Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children. , 2016, Vaccine.

[4]  E. Lau,et al.  Adiposity and influenza-associated respiratory mortality: a cohort study. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. McCullers,et al.  Comparison of Immune Response to the Influenza Vaccine in Obese and Nonobese Healthcare Workers , 2015, Infection Control & Hospital Epidemiology.

[6]  D. Metzger,et al.  Expression of Suppressor of Cytokine Signaling 1 (SOCS1) Impairs Viral Clearance and Exacerbates Lung Injury during Influenza Infection , 2014, PLoS pathogens.

[7]  K. Schmader,et al.  Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. , 2014, The Journal of infectious diseases.

[8]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[9]  R. Davey,et al.  Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies , 2014, PloS one.

[10]  J. Nam,et al.  Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine , 2014, Human vaccines & immunotherapeutics.

[11]  S. Rutherford,et al.  Body mass index and risk of pneumonia: a systematic review and meta‐analysis , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[12]  Qing,et al.  Diet-Induced Obese Mice Exhibit Altered Heterologous Immunity during a Secondary 2009 Pandemic H1N1 Infection , 2013, The Journal of Immunology.

[13]  A. Ferrante,et al.  The immune cells in adipose tissue , 2013, Diabetes, obesity & metabolism.

[14]  Mark Loeb,et al.  Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis , 2013, BMJ.

[15]  Jun Cheng,et al.  Microarray analysis of MicroRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1) , 2013, BMC Infectious Diseases.

[16]  Z. Bi,et al.  Risk factors associated with severe manifestations of 2009 pandemic influenza A (H1N1) infection in China: a case–control study , 2013, Virology Journal.

[17]  K. To,et al.  Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. , 2013, The Journal of infectious diseases.

[18]  M. Jensen,et al.  Leptin-based adjuvants: an innovative approach to improve vaccine response. , 2013, Vaccine.

[19]  J. Syrjänen,et al.  Obesity and the risk and outcome of infection , 2013, International Journal of Obesity.

[20]  Jonathan R. Iredell,et al.  Viral Pneumonitis Is Increased in Obese Patients during the First Wave of Pandemic A(H1N1) 2009 Virus , 2013, PloS one.

[21]  T. Lam,et al.  Obesity and influenza associated mortality: evidence from an elderly cohort in Hong Kong. , 2013, Preventive medicine.

[22]  J. Brownstein,et al.  Relationship between community prevalence of obesity and associated behavioral factors and community rates of influenza‐related hospitalizations in the United States , 2012, Influenza and other respiratory viruses.

[23]  E. Cordero,et al.  Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave. , 2012, The Journal of infection.

[24]  R. Webby,et al.  Review on the impact of pregnancy and obesity on influenza virus infection , 2012, Influenza and other respiratory viruses.

[25]  A. Monto,et al.  Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  T. Chotpitayasunondh,et al.  A review on the clinical spectrum and natural history of human influenza. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[27]  P. Shao,et al.  Risk factors of severe novel influenza A (H1N1) infections in hospitalized children. , 2012, Journal of the Formosan Medical Association = Taiwan yi zhi.

[28]  K. Crimin,et al.  Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. , 2012, Vaccine.

[29]  P. Horby,et al.  The Role of Host Genetics in Susceptibility to Influenza: A Systematic Review , 2012, PloS one.

[30]  Maria Zambon,et al.  Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. , 2012, The Lancet. Infectious diseases.

[31]  H. Poo,et al.  Association of Glutathione S-transferase genes (GSTM1 and GSTT1) polymorphisms with hypertension in lead-exposed workers , 2012, Molecular & Cellular Toxicology.

[32]  R. Webby,et al.  Impaired wound healing predisposes obese mice to severe influenza virus infection. , 2012, The Journal of infectious diseases.

[33]  M. Hudgens,et al.  Obesity is associated with impaired immune response to influenza vaccination in humans , 2011, International Journal of Obesity.

[34]  Susanna Price,et al.  Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). , 2011, JAMA.

[35]  D. Hui,et al.  Cytokine Response Patterns in Severe Pandemic 2009 H1N1 and Seasonal Influenza among Hospitalized Adults , 2011, PloS one.

[36]  M. Pai,et al.  Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary , 2011, Antimicrobial Agents and Chemotherapy.

[37]  L. Rosella,et al.  Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort Study , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  K. Ansel,et al.  MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. , 2011, Immunity.

[39]  Christl A. Donnelly,et al.  Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis , 2011, PLoS medicine.

[40]  S. Toovey,et al.  Body mass index and the incidence of influenza‐associated pneumonia in a UK primary care cohort , 2011, Influenza and other respiratory viruses.

[41]  M. Hell,et al.  Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria , 2011, Infection.

[42]  J. Taubenberger,et al.  Obese mice have increased morbidity and mortality compared to non‐obese mice during infection with the 2009 pandemic H1N1 influenza virus , 2011, Influenza and other respiratory viruses.

[43]  F. Tacke,et al.  Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. , 2011, Journal of critical care.

[44]  Kwok-Hung Chan,et al.  Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  D. Vugia,et al.  A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  J. Rello,et al.  Impact of obesity in patients infected with 2009 influenza A(H1N1). , 2011, Chest.

[47]  Nan Li,et al.  MicroRNA-148/152 Impair Innate Response and Antigen Presentation of TLR-Triggered Dendritic Cells by Targeting CaMKIIα , 2010, The Journal of Immunology.

[48]  M. Callaghan,et al.  Epidemiology, clinical characteristics and resource implications of pandemic (H1N1) 2009 in intensive care units in Ireland. , 2010, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[49]  C. Ciuce,et al.  Clinical aspects and cytokine response in severe H1N1 influenza A virus infection , 2010, Critical care.

[50]  E. Karlsson,et al.  Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. , 2010, The Journal of nutrition.

[51]  C. Tsatsanis,et al.  Association between H1N1 infection severity and obesity-adiponectin as a potential etiologic factor. , 2010, The Journal of infectious diseases.

[52]  M. Falagas,et al.  Clinical Features, Risk Factors, and Complications Among Pediatric Patients With Pandemic Influenza A (H1N1) , 2010, Clinical pediatrics.

[53]  P. Valdez,et al.  Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. , 2010, American journal of respiratory and critical care medicine.

[54]  W. Lim,et al.  Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009) , 2010, Thorax.

[55]  D. Heyland,et al.  Extreme obesity and outcomes in critically ill patients. , 2010, Chest.

[56]  Samson S. Y. Wong,et al.  Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  A. Fowlkes,et al.  Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease , 2010, PloS one.

[58]  J. Rello,et al.  Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza , 2010, Canadian Medical Association Journal.

[59]  R. Bellomo,et al.  Critical care services and 2009 H1N1 influenza in Australia and New Zealand. , 2009, The New England journal of medicine.

[60]  M. Meade,et al.  Critically ill patients with 2009 influenza A(H1N1) infection in Canada. , 2009, JAMA.

[61]  Robert Schechter,et al.  Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. , 2009, JAMA.

[62]  Diana Elbourne,et al.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial , 2009, The Lancet.

[63]  M. Beck,et al.  Diet-Induced Obesity Impairs the T Cell Memory Response to Influenza Virus Infection , 2009, The Journal of Immunology.

[64]  P. Pronovost,et al.  The impact of obesity on outcomes after critical illness: a meta-analysis , 2009, Intensive Care Medicine.

[65]  R. Greenlee,et al.  Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. , 2009, The Journal of infectious diseases.

[66]  M. Beck,et al.  Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. , 2007, The Journal of nutrition.

[67]  P. Doherty,et al.  A question of self‐preservation: immunopathology in influenza virus infection , 2007, Immunology and cell biology.

[68]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[69]  A. Martí,et al.  Obesity and immune function relationships , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[70]  W. Willett,et al.  Global obesity: trends, risk factors and policy implications , 2013, Nature Reviews Endocrinology.

[71]  G. Caire-Juvera,et al.  Decreased interferon-α and interferon-β production in obesity and expression of suppressor of cytokine signaling. , 2013, Nutrition.

[72]  J. Rello,et al.  First influenza season after the 2009 pandemic influenza: report of the first 300 ICU admissions in Spain. , 2011, Medicina intensiva.

[73]  Keiji Fukuda,et al.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.